LONG-TERM LOW-DOSE MELPHALAN TREATMENT OF MULTIPLE-MYELOMA

被引：9
|
作者：
BROOK, J
BATEMAN, JR
GOCKA, EF
NAKAMURA, E
STEINFELD, JL
机构：
[1] UNIV WASHINGTON, SEATTLE, WA 98105 USA
[2] UNIV UTAH, SALT LAKE CITY, UT 84112 USA
[3] UNIV SAN FRANCISCO, SAN FRANCISCO, CA 94117 USA
[4] VET ADM HOSP, WESTERN RES SUPPORT CTR, SEPULVA, CA 91343 USA
[5] VET ADM HOSP, LOS ANGELES, CA 90073 USA
[6] VET ADM HOSP, PACIFIC CANC CHEMOTHERAPY GRP, LONG BEACH, CA 90801 USA
[7] VET ADM HOSP, WESTERN COOPERAT CANC CHEMOTHERAPY GRP, LONG BEACH, CA 90801 USA
[8] UNIV SO CALIF, LOS ANGELES, CA 90007 USA
[9] UNIV CALIF, LOS ANGELES, CA 90024 USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 1973年 / 131卷 / 04期
关键词：
D O I：
10.1001/archinte.1973.00320100073009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：545 / 548
页数：4
相关论文
共 50 条
  • [31] MELPHALAN AND MYELOMA - EXPERIENCE WITH A LOW-DOSE CONTINUOUS REGIMEN
    MCARTHUR, JR
    ATHENS, JW
    WINTROBE, MM
    CARTWRIGHT, GE
    ANNALS OF INTERNAL MEDICINE, 1970, 72 (05) : 665 - +
  • [32] TREATMENT OF MULTIPLE-MYELOMA AND MACROGLOBULINEMIA WALDENSTROM - LONG-TERM FOLLOW-UP STUDY
    ONODERA, S
    OHTAKI, M
    OIKAWA, K
    MIKAMI, M
    SATO, I
    NIIKAWA, K
    SUZUKI, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 116 (04): : 317 - 325
  • [33] EFFICACY OF LONG-TERM CONTINUED PULSE REGIMEN OF ALKERAN AND PREDNISONE IN TREATMENT OF MULTIPLE-MYELOMA
    SABA, HI
    LYMAN, GH
    DINWOODIE, WR
    HARTMANN, RC
    CLINICAL RESEARCH, 1978, 26 (03): : A441 - A441
  • [34] PROGNOSTIC FACTORS WITH HIGH-DOSE MELPHALAN FOR REFRACTORY MULTIPLE-MYELOMA
    BARLOGIE, B
    ALEXANIAN, R
    SMALLWOOD, L
    CHESON, B
    DIXON, D
    DICKE, K
    CABANILLAS, F
    BLOOD, 1988, 72 (06) : 2015 - 2019
  • [35] MULTIPLE-MYELOMA - COMPLETE REMISSION WITH HIGH-DOSE MELPHALAN CHEMOTHERAPY
    RICHARDS, F
    COLEMAN, M
    COOPER, MR
    BALLARD, WP
    CANCER INVESTIGATION, 1985, 3 (01) : 15 - 21
  • [36] ORAL LOW-DOSE ETOPOSIDE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA WITH EXTRAMEDULLARY INVOLVEMENT
    KATO, Y
    TAKEDA, H
    MIHARA, H
    KOBAYASHI, H
    KAMIJIMA, S
    KUWAHARA, M
    OGURI, T
    NAGASAKA, T
    INTERNAL MEDICINE, 1995, 34 (10) : 1023 - 1026
  • [37] LOW-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY IN ADVANCED MULTIPLE-MYELOMA
    PEEST, D
    LEO, R
    BLOCHE, S
    HEIN, R
    STANNATKIESSLING, S
    TSCHECHNE, B
    FETT, W
    HARMS, P
    HOFFMANN, L
    BARTL, R
    WACKER, HH
    GORG, S
    ATZPODIEN, J
    KIRCHNER, H
    DEICHER, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) : 328 - 337
  • [38] CARCINOMA OF BREAST - OCCURRENCE AFTER TREATMENT WITH MELPHALAN FOR MULTIPLE-MYELOMA
    BELL, R
    SULLIVAN, JR
    FONE, DJ
    HURLEY, TH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (14): : 1609 - 1610
  • [39] A COMPARISON OF ORAL MELPHALAN, CCNU AND BCNU IN THE TREATMENT OF MULTIPLE-MYELOMA
    CORNWELL, GG
    PAJAK, TF
    MCINTYRE, OR
    KOCHWA, S
    SCHWARTZ, JM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 537 - 537
  • [40] RESULTS OF TREATMENT OF MULTIPLE-MYELOMA BY THE ASSOCIATION VINCRISTIN-MELPHALAN
    ROUX, H
    DOMEZON, Y
    GABORIT, P
    EISINGER, F
    SERRATRICE, G
    REVUE DU RHUMATISME, 1979, 46 (7-9): : 443 - 448
12345